|
From
•>>April 2006
Andrea Cerutti answers
a few questions about this month's emerging research front
in
field of Immunology: Immunology
Article: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Authors: Litinskiy, MB;Nardelli, B;Hilbert, DM;He, B;Schaffer, A;Casali,
P;Cerutti, A
Journal: NAT IMMUNOL 142 2002, 3 (9): 822-829 SEP 2002
Addresses:
Cornell Univ, Div Mol Immunol, Dept Pathol & Lab Med, Joan & Sanford L Weill Med Coll, 1300 York Ave, New York, NY 10021 USA.
Cornell Univ, Div Mol Immunol, Dept Pathol & Lab Med, Joan & Sanford L Weill Med Coll, New York, NY 10021 USA.
Human Genome Sci, Rockville, MD 20850 USA.
|
|

Why do you think your paper is
highly cited?
|

“Our paper describes an alternative pathway for the production of
IgG, IgA and IgE antibodies...”
|
|
By substituting immunoglobulin (Ig) M with IgG, IgA, or IgE,
class switching diversifies the effector functions of
antibodies produced by mature B cells, thereby facilitating
the clearance of invading microorganisms by the immune system.
Class switching is thought to be highly dependent upon
activation of B cells by CD4+ T cells, a cell type that
orchestrates cellular and humoral immune responses by
providing help to T cells and B cells, respectively.
Our paper shows for the first time that B cells can undergo
CD40-independent class switching upon activation by CD40L-like
factors produced by dendritic cells. These immune cells are
distributed as sentinels throughout our body and initiate
immune responses by capturing microbial products and
presenting them to CD4+ T cells. Our findings indicate that
dendritic cells have a hitherto unsuspected flexibility as
they can initiate IgG, IgA, and IgE responses by activating B
cells in a T cell-independent fashion.
Does it describe a new discovery or a new methodology
that's useful to others?
Our paper describes an alternative pathway for the
production of IgG, IgA, and IgE antibodies, which are
essential for the clearance of microorganisms and their
products both systemically and at portal sites of entry,
including respiratory, intestinal, and urogenital mucosal
surfaces. In addition to furthering our understanding of
antibody responses against infectious agents, our research may
help in elucidating antibody-mediated autoimmune disorders,
such as lupus and rheumatoid arthritis.
Could you summarize the significance of your paper in
layman's terms?
Our findings provide a novel mechanistic explanation for
previously published studies indicating that B cells lodged
within mucosal surfaces can produce IgG, IgA, and IgE
antibodies in the absence of CD4+ T cell help. Unlike T
cell-dependent antibody responses, which require five to seven
days, T cell-independent antibody responses require only one
to three days, thereby enabling the immune system to control
infections at a very early time point. Thus, our observations
further our understanding of a key immune process.
How did you become involved in this research, and were
there successes or failures along the way?
I have a long-standing interest in the regulation of Ig
heavy chain class switching and I have always been puzzled by
the mechanisms underlying front line T cell-independent IgG,
IgA, and IgE responses. Data published by other investigators
showing dendritic cell production of powerful B
cell-activating factors made me hypothesize the involvement of
dendritic cells in the initiation of class switching during
"front line" B cell responses. Compared to other
projects previously developed in our lab, this was a
relatively straightforward research endeavor.
If applicable, what are the social or political
implications of your research?
Although conferring greater flexibility to B cells, the T
cell-independent pathway described in our paper may have an
autoimmune downside, as class switch-inducing factors produced
by dendritic cells are implicated in lupus and rheumatoid
arthritis, two relatively frequent autoimmune disorders
characterized by production of IgG and IgA with abnormal
reactivity against certain components of our own body.
By showing that certain compounds are capable of blocking
dendritic cell-induced IgG and IgA production, our findings
outline a novel therapeutic strategy that may help in reducing
the social costs associated with antibody-mediated autoimmune
disorders.
Andrea Cerutti, M.D.
Assistant Professor
Pathology and Laboratory Medicine
Graduate Program in Immunology & Microbial Pathogenesis
Weill Medical College of Cornell University
New York, NY, USA
|
Return to Emerging Research Fronts | Return
to Special Topics main menu
|